Parade aims to feature only the best products and services. If you buy something via one o...
The invite to Aurangzeb Khan Khichi is the first from New Delhi to a Pakistani official si...
At least 39 people have been killed after two high-speed trains collided near Urda, Spain.
If the phrase “music festival” immediately conjures up visions of standing for eight hours...
Christmas movies are in full swing over at Great American Family and this weekend offers u...
Countries
Opinion
Abdul El-Sayed’s toxic ‘academic research’ reveals his anti-American Muslim supremacy
Broke, woke and armed with a crazy plan: Pay the lunatics running the asylum even more
- PR Newswire ( Middle East ) 2026/10/24
BEIJING, Oct. 24, 2026 /PRNewswire/ -- Likang Life Sciences ("Likang"), a biotechnology company advancing AI-enabled personalized cancer imm...
- Gizmodo ( Middle East ) 2026/9/18
Scientists are developing new forms of CAR T cell therapy that may finally be able to treat solid tumors.
- PR Newswire ( Middle East ) 2026/8/12
TAIPEI and SAN DIEGO, Aug. 12, 2026 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492) today announced a significant research advance inv...
- PR Newswire ( Middle East ) 2026/8/10
MILWAUKEE, Aug. 10, 2026 /PRNewswire/ -- Reinforcing its commitment to advancing cancer immunotherapy through research and education, the So...
- PR Newswire ( Middle East ) 2026/8/10
Newly recruiting Phase 1 study will evaluate a next-generation KRAS-targeted immunotherapy, revealing how pancreatic tumor microenvironment...
- PR Newswire ( Middle East ) 2026/8/2
Minjuvi® (tafasitamab), in combination with rituximab and lenalidomide, is the first and only chemotherapy-free CD19 and CD20 dual-targeted...
- PR Newswire ( Middle East ) 2026/6/26
Breast cancer vaccine presentation includes final Phase 1 data showing all major primary endpoints were met and protocol-defined immune resp...
- PR Newswire ( Middle East ) 2026/5/22
SAN FRANCISCO and SUZHOU, China, May 21, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmace...
- NY Times News ( Middle East ) 2026/5/4
Thousands of patients across England each year will benefit from a new immunotherapy treatment that can be used for several types of cance...
- PR Newswire ( Middle East ) 2026/4/22
NEWARK, Del., April 22, 2026 /PRNewswire/ -- According to a latest market analysis by Future Market Insights, the global lung cancer therape...
- PR Newswire ( Middle East ) 2026/3/17
Prof. Andreas Lundqvist's group will use Pixelgen's Proximity Network Assay to explore spatial distribution and abundance of single cell sur...
- PR Newswire ( Middle East ) 2026/3/7
SHANGHAI, March 6, 2026 /PRNewswire/ -- Jiahui International Cancer Center (JICC) has stabilized a U.S. patient with advanced non‑small cell...
- PR Newswire ( Middle East ) 2026/3/3
TAIPEI and SAN DIEGO, March 3, 2026 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical stage company focusing on development...
- PR Newswire ( Middle East ) 2026/2/22
More than 60% of participant dietary consumption plans showed no significant difference between omalizumab and multi-food oral immunotherapy...
- PR Newswire ( Middle East ) 2026/1/16
BELLEVUE, Wash., Jan. 16, 2026 /PRNewswire/ -- Vaximm AG, a subsidiary of OSR Holdings, Inc. and a pioneer in oral T-cell immunotherapies fo...